|
Delayed
Nasdaq
06:21:52 07/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.8220 USD | +9.47% |
|
-1.80% | +18.67% |
| 06/11 | Elutia Inc., Q3 2026 Earnings Call, Nov 05, 2026 | |
| 06/11 | Elutia Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| Market Cap | 33.26M 29.83M 27.26M 24.88M 46.88M 3.13B 48.36M 329M 131M 1.67B 125M 122M 5.27B | P/E 2026 * |
-1.19x | P/E 2027 * | -1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 33.26M 29.83M 27.26M 24.88M 46.88M 3.13B 48.36M 329M 131M 1.67B 125M 122M 5.27B | EV / Sales 2026 * |
4.43x | EV / Sales 2027 * | 7.73x |
| Free-Float |
85.18% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ELUT | Delayed | |
CBOE
| ELUT | Real-time |
Last Transcript: Elutia Inc.
| 1 day | +9.47% | ||
| 1 week | -1.80% | ||
| Current month | -1.80% | ||
| 1 month | +5.81% | ||
| 3 months | -6.70% | ||
| 6 months | -19.41% | ||
| Current year | +18.67% |
| 1 week | 0.7 |  | 0.86 |
| 1 month | 0.7 | | 0.88 |
| Current year | 0.6 | | 1.38 |
| 1 year | 0.5 | | 1.38 |
| 3 years | 0.5 | | 5.24 |
| 5 years | 0.5 | | 9.01 |
| 10 years | 0.5 | | 18.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Operating Officer | 52 | - | |
Charles Mills
CEO | Chief Executive Officer | 54 | 21/06/2022 |
Matthew Ferguson
DFI | Director of Finance/CFO | 58 | 28/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Rakin
CHM | Chairman | 65 | 01/11/2015 |
Charles Mills
BRD | Director/Board Member | 54 | 01/11/2015 |
Brigid Makes
BRD | Director/Board Member | 70 | 01/09/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/9/26 | Exercice | Founder | 63,884 | 0.1445% | ||
| 10/9/26 | Exercice | Founder | 29,269 | 0.0662% | ||
| 10/9/26 | Exercice | Chief Financial Officer | 29,486 | 0.0667% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.47% | -1.80% | -12.76% | -40.43% | 33.26M | |
| -0.08% | -3.94% | +45.26% | +128.78% | 1,216B | |
| +1.28% | +0.80% | +47.28% | +81.53% | 656B | |
| +0.60% | -1.49% | +32.62% | +105.74% | 509B | |
| -0.36% | -3.25% | +47.17% | +64.58% | 384B | |
| -0.18% | -1.89% | +71.02% | +40.60% | 362B | |
| -0.78% | -0.52% | +30.57% | +57.98% | 311B | |
| -0.80% | -0.21% | +8.54% | +35.56% | 293B | |
| +0.20% | -0.97% | +46.22% | +69.14% | 249B | |
| +0.01% | -1.54% | +36.19% | +107.12% | 208B | |
| Average | +0.86% | -0.23% | +35.21% | +65.06% | 418.78B | |
| Weighted average by Cap. | +0.03% | +0.03% | +42.39% | +88.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.5M 6.73M 6.15M 5.61M 10.57M 705M 10.91M 74.1M 29.55M 376M 28.15M 27.55M 1.19B | 4.3M 3.86M 3.52M 3.22M 6.06M 404M 6.25M 42.48M 16.94M 216M 16.14M 15.79M 681M |
| Net income | -27.3M -24.49M -22.38M -20.43M -38.49M -2.57B -39.7M -270M -108M -1.37B -102M -100M -4.32B | -23.6M -21.17M -19.34M -17.66M -33.27M -2.22B -34.32M -233M -92.98M -1.18B -88.58M -86.68M -3.74B |
| Net Debt | - | - |
Employees
26
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/11/26 | USD 0.8220 | +9.47% | 49,158 |
| 05/11/26 | USD 0.7509 | -1.15% | 87,544 |
| 04/11/26 | USD 0.7596 | -6.59% | 93,539 |
| 03/11/26 | USD 0.8132 | -0.95% | 37,677 |
| 02/11/26 | USD 0.8210 | -1.92% | 34,648 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.7509USD
Average target price
5.000USD
Spread / Average Target
+565.87%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ELUT Stock
Select your edition
All financial news and data tailored to specific country editions
